Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2015

Open Access 01-12-2015 | Research

Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain

Authors: Javier Mar, Jaime Masjuan, Juan Oliva-Moreno, Nuria Gonzalez-Rojas, Virginia Becerra, Miguel Ángel Casado, Covadonga Torres, María Yebenes, Manuel Quintana, Jose Alvarez-Sabín, on behalf of CONOCES Investigators Group

Published in: Health and Quality of Life Outcomes | Issue 1/2015

Login to get access

Abstract

Introduction

The primary objective of this sub analysis of the CONOCES study was to analyse outcomes in terms of mortality rates, quality of life and degree of autonomy over the first year in patients admitted to stroke units in Spain. The secondary objective was to identify the factors determining good prognosis.

Methods

We studied a sample of patients who had suffered a confirmed stroke and been admitted to a Stroke Unit in the Spanish healthcare system. Socio-demographic and clinical variables and variables related to the level of severity (NIHSS), the level of autonomy (Barthel, modified Rankin) and quality of life (EQ-5D) were recorded at the time of admission and then three months and one year after the event. Factors determining prognosis were analysed using logistic regression and ROC curves.

Results

A total of 321 patients were recruited, 33% of whom received thrombolytic treatment, which was associated with better results on the Barthel and the modified Rankin scales and in terms of the risk of death. Mean quality of life measured through EQ-5D improved from 0.57 at discharge to 0.65 one year later. Full autonomy level measured by Barthel index increased from 30.1% at discharge to 52.8% at one year and by the modified Rankin scale from 51% to 71%. The rates for in-hospital and 1-year mortality were 5.9% and 17.4% respectively. Low NIHSS scores were associated with a good prognosis with all the outcome variables. The three instruments applied (NIHSS, Barthel and modified Rankin scales) on admission showed good discriminative ability for patient prognosis in the ROC curves.

Conclusions

There has been a change in the prognosis for stroke in Spain in recent years as the quality of life at 1 year observed in our study is clearly higher than that obtained in other Spanish studies conducted previously. Moreover, survival and functional outcome have also improved following the introduction of a new model of care. These results clearly promote extension of the model based on stroke units and reinforced rehabilitation to the majority of the more than 100,000 strokes that occur annually in Spain.
Literature
2.
go back to reference Adams HP, Kassell NF, Mazuz H. The patient with transient ischemic attacks. Is this time for a new therapeutic approach? Stroke. 1984;15:371–5.CrossRefPubMed Adams HP, Kassell NF, Mazuz H. The patient with transient ischemic attacks. Is this time for a new therapeutic approach? Stroke. 1984;15:371–5.CrossRefPubMed
3.
go back to reference Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: scientific review. JAMA. 2002;288:1388–95.CrossRefPubMed Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: scientific review. JAMA. 2002;288:1388–95.CrossRefPubMed
4.
go back to reference Goldberg G, Berger GG. Secondary prevention in stroke: a primary rehabilitation concern. Arch Physical Med Rehabilitation. 1988;69:32–40. Goldberg G, Berger GG. Secondary prevention in stroke: a primary rehabilitation concern. Arch Physical Med Rehabilitation. 1988;69:32–40.
5.
go back to reference Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–22. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–22.
6.
go back to reference The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.CrossRef The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.CrossRef
7.
go back to reference Brott T, Bogousslavsky J. Drug therapy: treatment of acute ischemic stroke. N Engl J Med. 2000;343:710–22.CrossRefPubMed Brott T, Bogousslavsky J. Drug therapy: treatment of acute ischemic stroke. N Engl J Med. 2000;343:710–22.CrossRefPubMed
8.
go back to reference Álvarez-Sabín J, Alonso de Leciñana M, Gallego J, Gil Peralta A, Casado I, Castillo J, et al. Plan de atención sanitaria del ictus. Neurologia. 2006;21:717–26.PubMed Álvarez-Sabín J, Alonso de Leciñana M, Gallego J, Gil Peralta A, Casado I, Castillo J, et al. Plan de atención sanitaria del ictus. Neurologia. 2006;21:717–26.PubMed
9.
go back to reference Masjuan J, Álvarez-Sabín J, Arenillas J, Calleja S, Castillo J, Dávalos A, et al. Plan de asistencia sanitaria al ictus ii. 2010. Neurologia. 2011;26:383–96.CrossRefPubMed Masjuan J, Álvarez-Sabín J, Arenillas J, Calleja S, Castillo J, Dávalos A, et al. Plan de asistencia sanitaria al ictus ii. 2010. Neurologia. 2011;26:383–96.CrossRefPubMed
10.
go back to reference Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database of Syst Rev. 2013. Issue 9. Art. No.: CD000197. doi:10.1002/14651858.CD000197.pub3. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database of Syst Rev. 2013. Issue 9. Art. No.: CD000197. doi:10.1002/14651858.CD000197.pub3.
11.
go back to reference Knapp M, Prince M. Dementia UK: The Full Report. London: Alzheimer’s Society; 2007. Knapp M, Prince M. Dementia UK: The Full Report. London: Alzheimer’s Society; 2007.
12.
go back to reference Rothwell PM. The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet. 2001;357:1612–6.CrossRefPubMed Rothwell PM. The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet. 2001;357:1612–6.CrossRefPubMed
13.
go back to reference Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245–54.CrossRefPubMedCentralPubMed Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245–54.CrossRefPubMedCentralPubMed
14.
go back to reference Catalá-López F, García-Altés A, Alvarez-Martín E, Gènova-Maleras R, Morant-Ginestar C, Parada A. Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters? BMC Health Serv Res. 2011;11:75.CrossRefPubMedCentralPubMed Catalá-López F, García-Altés A, Alvarez-Martín E, Gènova-Maleras R, Morant-Ginestar C, Parada A. Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters? BMC Health Serv Res. 2011;11:75.CrossRefPubMedCentralPubMed
15.
go back to reference Carod-Artal FJ. Medición de la calidad de vida en supervivientes de un ictus. Rev Neurol. 1999;29:447–56.PubMed Carod-Artal FJ. Medición de la calidad de vida en supervivientes de un ictus. Rev Neurol. 1999;29:447–56.PubMed
16.
go back to reference Lopez-Bastida J, Oliva Moreno J, Worbes Cerezo M, Perestelo Perez L, Serrano-Aguilar P, Montón-Álvarez F. Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain. BMC Health Serv Res. 2012;12:315.CrossRefPubMedCentralPubMed Lopez-Bastida J, Oliva Moreno J, Worbes Cerezo M, Perestelo Perez L, Serrano-Aguilar P, Montón-Álvarez F. Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain. BMC Health Serv Res. 2012;12:315.CrossRefPubMedCentralPubMed
17.
go back to reference Mar J, Arrospide A, Begiristain JM, Larrañaga I, Elosegui E, Oliva-Moreno J. The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life. BMC Neurol. 2011;11:46.CrossRefPubMedCentralPubMed Mar J, Arrospide A, Begiristain JM, Larrañaga I, Elosegui E, Oliva-Moreno J. The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life. BMC Neurol. 2011;11:46.CrossRefPubMedCentralPubMed
18.
go back to reference Hankey GJ. Stroke Treatment and Prevention: an Evidence-Based Approach. New York: Cambridge University Press; 2005.CrossRef Hankey GJ. Stroke Treatment and Prevention: an Evidence-Based Approach. New York: Cambridge University Press; 2005.CrossRef
19.
go back to reference Mar J, Álvarez-Sabín J, Oliva J, Becerra V, Casado MÁ, Yébenes M, et al. The costs of stroke in Spain by aetiology: the CONOCES study protocol. Neurologia. 2013;28:332–9.CrossRefPubMed Mar J, Álvarez-Sabín J, Oliva J, Becerra V, Casado MÁ, Yébenes M, et al. The costs of stroke in Spain by aetiology: the CONOCES study protocol. Neurologia. 2013;28:332–9.CrossRefPubMed
20.
go back to reference Brott T, Marler JR, Olinger CP, Adams Jr HP, Tomsick T, Barsan WG, et al. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke. 1989;20:871–5.CrossRefPubMed Brott T, Marler JR, Olinger CP, Adams Jr HP, Tomsick T, Barsan WG, et al. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke. 1989;20:871–5.CrossRefPubMed
21.
go back to reference Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md Med J. 1965;14:61–5. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md Med J. 1965;14:61–5.
22.
go back to reference van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.CrossRefPubMed van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.CrossRefPubMed
23.
go back to reference Cid-Ruzafa J, Damián-Moreno J. Valoración de la discapacidad física: el indice de Barthel. Rev Esp Salud Publica. 1997;71:127–37.CrossRefPubMed Cid-Ruzafa J, Damián-Moreno J. Valoración de la discapacidad física: el indice de Barthel. Rev Esp Salud Publica. 1997;71:127–37.CrossRefPubMed
24.
go back to reference Wityk RJ, Pessin MS, Kaplan RF, Caplan LR. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke. 1994;25:362–5. Erratum in: Stroke 1994; 25:1300.CrossRefPubMed Wityk RJ, Pessin MS, Kaplan RF, Caplan LR. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke. 1994;25:362–5. Erratum in: Stroke 1994; 25:1300.CrossRefPubMed
25.
go back to reference Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989;46:660–2.CrossRefPubMed Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989;46:660–2.CrossRefPubMed
26.
go back to reference Group EQL. EuroQoL - a new facility for measurement of health -related quality of life. Health Policy. 1990;16:199–208.CrossRef Group EQL. EuroQoL - a new facility for measurement of health -related quality of life. Health Policy. 1990;16:199–208.CrossRef
27.
go back to reference Badía X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc). 1999;112(supl 1):S79–86. Badía X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc). 1999;112(supl 1):S79–86.
28.
go back to reference Sneew KCA, Aaronson NK, de Haan RJ, Limburg M. Assessing quality of life after stroke: the value and limitations of proxy ratings. Stroke. 1997;28:1541–9.CrossRef Sneew KCA, Aaronson NK, de Haan RJ, Limburg M. Assessing quality of life after stroke: the value and limitations of proxy ratings. Stroke. 1997;28:1541–9.CrossRef
29.
go back to reference Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press; 1977. p. 8. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press; 1977. p. 8.
30.
go back to reference Oliva-Moreno J, Lopez-Bastida J, Worbes-Cerezo M, Serrano-Aguilar P. Health related quality of life of Canary Island citizens. BMC Public Health. 2010;10:675.CrossRefPubMedCentralPubMed Oliva-Moreno J, Lopez-Bastida J, Worbes-Cerezo M, Serrano-Aguilar P. Health related quality of life of Canary Island citizens. BMC Public Health. 2010;10:675.CrossRefPubMedCentralPubMed
31.
go back to reference Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis. 1986;39:897–906.CrossRefPubMed Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis. 1986;39:897–906.CrossRefPubMed
32.
go back to reference Arrazola A, Beguiristain JM, Garitano B, Mar J, Elizalde B. Hospital care of cerebrovascular accident and the state of patients 12 months after. Rev Neurol. 2005;40:326–30.PubMed Arrazola A, Beguiristain JM, Garitano B, Mar J, Elizalde B. Hospital care of cerebrovascular accident and the state of patients 12 months after. Rev Neurol. 2005;40:326–30.PubMed
33.
go back to reference Whiteley WN, Thompson D, Murray G, Cohen G, Lindley RI, Wardlaw J, et al. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial. Stroke. 2014;45:1000–6.CrossRefPubMedCentralPubMed Whiteley WN, Thompson D, Murray G, Cohen G, Lindley RI, Wardlaw J, et al. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial. Stroke. 2014;45:1000–6.CrossRefPubMedCentralPubMed
34.
go back to reference Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis. 2003;16 Suppl 1:14–9.CrossRefPubMed Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis. 2003;16 Suppl 1:14–9.CrossRefPubMed
35.
go back to reference Orfila F, Ferrer M, Lamarca R, Tebe C, Domingo-Salvany A, Alonso J. Gender differences in health-related quality of life among the elderly: the role of objective functional capacity and chronic conditions. Soc Sci Med. 2006;63:2367–80.CrossRefPubMed Orfila F, Ferrer M, Lamarca R, Tebe C, Domingo-Salvany A, Alonso J. Gender differences in health-related quality of life among the elderly: the role of objective functional capacity and chronic conditions. Soc Sci Med. 2006;63:2367–80.CrossRefPubMed
36.
go back to reference Mar J, Begiristain JM, Arrazola A. Cost-effectiveness analysis of thrombolytic treatment for stroke. Cerebrovasc Dis. 2005;20:193–200.CrossRefPubMed Mar J, Begiristain JM, Arrazola A. Cost-effectiveness analysis of thrombolytic treatment for stroke. Cerebrovasc Dis. 2005;20:193–200.CrossRefPubMed
37.
go back to reference Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5:70.CrossRefPubMedCentralPubMed Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5:70.CrossRefPubMedCentralPubMed
38.
go back to reference Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, the clinical significance consensus meeting group. Methods to Explain the Clinical Significance of Health Status Measures. Mayo Clin Proc. 2002;77:371–83.CrossRefPubMed Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, the clinical significance consensus meeting group. Methods to Explain the Clinical Significance of Health Status Measures. Mayo Clin Proc. 2002;77:371–83.CrossRefPubMed
39.
go back to reference Ovbiagele B. Nationwide trends in in-hospital mortality among patients with stroke. Stroke. 2010;41:1748–54.CrossRefPubMed Ovbiagele B. Nationwide trends in in-hospital mortality among patients with stroke. Stroke. 2010;41:1748–54.CrossRefPubMed
40.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.CrossRefPubMed
41.
go back to reference Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.CrossRefPubMed Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.CrossRefPubMed
42.
go back to reference Wiedmann S, Hillmann S, Abilleira S, Dennis M, Hermanek P, Niewada M, et al. Variations in acute hospital stroke care and factors influencing adherence to quality indicators in 6 European audits. Stroke. 2015;46:579–81.CrossRefPubMed Wiedmann S, Hillmann S, Abilleira S, Dennis M, Hermanek P, Niewada M, et al. Variations in acute hospital stroke care and factors influencing adherence to quality indicators in 6 European audits. Stroke. 2015;46:579–81.CrossRefPubMed
43.
go back to reference Wiedmann S, Norrving B, Nowe T, Abilleira S, Asplund K, Dennis M, et al. Variations in quality indicators of acute stroke care in 6 European countries: the European Implementation Score (EIS) Collaboration. Stroke. 2012;43(2):458–63.CrossRefPubMed Wiedmann S, Norrving B, Nowe T, Abilleira S, Asplund K, Dennis M, et al. Variations in quality indicators of acute stroke care in 6 European countries: the European Implementation Score (EIS) Collaboration. Stroke. 2012;43(2):458–63.CrossRefPubMed
44.
go back to reference López Fernández JC, Masjuan Vallejo J, Arenillas Lara J, Blanco González M, Botia Paniagua E, Casado Naranjo I, et al. Analysis of stroke care resources in Spain in 2012: have we benefitted from the Spanish Health System’s stroke care strategy? Neurologia. 2014;29(7):387–96.CrossRefPubMed López Fernández JC, Masjuan Vallejo J, Arenillas Lara J, Blanco González M, Botia Paniagua E, Casado Naranjo I, et al. Analysis of stroke care resources in Spain in 2012: have we benefitted from the Spanish Health System’s stroke care strategy? Neurologia. 2014;29(7):387–96.CrossRefPubMed
45.
go back to reference Brea A, Laclaustra M, Martorell E, Pedragosa A. Epidemiology of cerebrovascular disease in Spain. Clin Investig Arterioscler. 2013;25:211–7.CrossRefPubMed Brea A, Laclaustra M, Martorell E, Pedragosa A. Epidemiology of cerebrovascular disease in Spain. Clin Investig Arterioscler. 2013;25:211–7.CrossRefPubMed
46.
go back to reference Pedragosa A, Alvarez-Sabín J, Rubiera M, Rodriguez-Luna D, Maisterra O, Molina C, et al. Impact of telemedicine on acute management of stroke patients undergoing endovascular procedures. Cerebrovasc Dis. 2012;34(5–6):436–42.CrossRefPubMed Pedragosa A, Alvarez-Sabín J, Rubiera M, Rodriguez-Luna D, Maisterra O, Molina C, et al. Impact of telemedicine on acute management of stroke patients undergoing endovascular procedures. Cerebrovasc Dis. 2012;34(5–6):436–42.CrossRefPubMed
Metadata
Title
Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain
Authors
Javier Mar
Jaime Masjuan
Juan Oliva-Moreno
Nuria Gonzalez-Rojas
Virginia Becerra
Miguel Ángel Casado
Covadonga Torres
María Yebenes
Manuel Quintana
Jose Alvarez-Sabín
on behalf of CONOCES Investigators Group
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2015
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-015-0230-8

Other articles of this Issue 1/2015

Health and Quality of Life Outcomes 1/2015 Go to the issue